Recombinant multi-species RENALASE/RNLS protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RENALASE/RNLS protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Renalase is a flavin adenine dinucleotide-dependent amine oxidase that is secreted into the blood from the kidney (Xu et al., 2005 [PubMed 15841207]).[supplied by OMIM, Mar 2008]
The Alternative Names of target: C10orf59,Monoamine oxidase-C (MAO-C),RENALASE,RGD1309804,RNLS,Renalase,Rnls

Target products collectionGo to RENALASE/RNLS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1252-Ag-1/ GM-Tg-hg-SE1252-Ag-2 Human RENALASE/RNLS protein Human
GM-Tg-rg-SE1252-Ag-1/ GM-Tg-rg-SE1252-Ag-2 Rat RENALASE/RNLS protein Rat
GM-Tg-mg-SE1252-Ag-1/ GM-Tg-mg-SE1252-Ag-2 Mouse RENALASE/RNLS protein Mouse
GM-Tg-cynog-SE1252-Ag-1/ GM-Tg-cynog-SE1252-Ag-2 Cynomolgus/Rhesus macaque RENALASE/RNLS protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1252-Ag-1/ GM-Tg-felg-SE1252-Ag-2 Feline RENALASE/RNLS protein Feline
GM-Tg-cang-SE1252-Ag-1/ GM-Tg-cang-SE1252-Ag-2 Canine RENALASE/RNLS protein Canine
GM-Tg-bovg-SE1252-Ag-1/ GM-Tg-bovg-SE1252-Ag-2 Bovine RENALASE/RNLS protein Bovine
GM-Tg-equg-SE1252-Ag-1/ GM-Tg-equg-SE1252-Ag-2 Equine RENALASE/RNLS protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1252-Ag-1/ GM-Tg-hg-SE1252-Ag-2; GM-Tg-rg-SE1252-Ag-1/ GM-Tg-rg-SE1252-Ag-2;
GM-Tg-mg-SE1252-Ag-1/ GM-Tg-mg-SE1252-Ag-2; GM-Tg-cynog-SE1252-Ag-1/ GM-Tg-cynog-SE1252-Ag-2;
GM-Tg-felg-SE1252-Ag-1/ GM-Tg-felg-SE1252-Ag-2; GM-Tg-cang-SE1252-Ag-1/ GM-Tg-cang-SE1252-Ag-2;
GM-Tg-bovg-SE1252-Ag-1/ GM-Tg-bovg-SE1252-Ag-2; GM-Tg-equg-SE1252-Ag-1/ GM-Tg-equg-SE1252-Ag-2
Products Name RENALASE/RNLS protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RENALASE/RNLS
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RENALASE/RNLS protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.